mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
0.14 |
0.4 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.4 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |